Anticancer Research is an international journal designed to rapidly publish original papers and reviews on experimental and clinical cancer research. Anticancer Research was established in 1981 by J.G. Delinasios. In this site you may find information concerning the editorial board, editorial policy, subscriptions, submission of manuscripts, online open articles, advertising, special offers for authors and a current list of accepted manuscripts.
New Anticancer Agents – 2025
1. TOPICS: A. Experimental studies on “New Anticancer Agents”
1. Synthesis and evaluation in vitro and in vivo
2. Mechanism of action
3. Reversal of resistance to anticancer agents
4. Oncolytic viruses
B. Clinical studies on “New Anticancer Agents”
1. Pharmacology
2. Clinical trials
3. Combination chemotherapy
4. Immunotherapeutic agents
5. New methodologies in drug delivery
6. Vaccines
2. Deadline for article(s) submission: May 10, 2025.
3. The instructions to Authors of ANTICANCER RESEARCH apply to this special issue, in the same way they apply to any ANTICANCER RESEARCH issue.
4. Review articles should preferably not exceed 12 printed pages, corresponding to roughly 48 typewritten pages or roughly 12,000 words. There will be no page charges. Color figures should be charged US $350 per page.
5. Original articles up to 4 printed pages corresponding to roughly 12 typewritten pages or roughly 4,000 words will not be subject to page charges. Articles exceeding 4 printed pages will be charged US $230 per excess page. Color figures will be charged US $350 per page. Discounts will be provided for long articles or/and articles with >2 color pages.
6. All submitted articles will be peer-reviewed. Upon acceptance each article will be edited for language and style improvements (if needed and at no cost) by our philological department. Authors will receive a response within 3-4 weeks from submission.
7. The special issue is scheduled for publication in July, 2025.
8. Manuscripts should be submitted for publication through our new online submission system: www.iiar-submissions.com
Advances in Renal Cell Carcinoma Diagnosis and Treatment– 2025
1. TOPICS: A. Advances in Renal Cell Carcinoma (RCC) Diagnosis
1. Biomarkers and molecular diagnostics
2. Imaging techniques
3. Non-invasive diagnostic tools
4. Risk stratification and prediction models
B. Advances in Renal Cell Carcinoma (RCC) Treatment
1. Targeted therapies
2. Immunotherapy
3. Combination treatment strategies
4. New methodologies in drug delivery
5. Surgical approaches and minimally invasive techniques
6. Metastatic renal cell carcinoma
7. Adverse effects and quality of life
C. Future Directions and Emerging Trends
1. Personalized and precision medicine in RCC
2. Clinical trials and emerging agents
3. Artificial intelligence in RCC treatment and diagnosis
2. Deadline for article(s) submission: July 10, 2025.
3. The instructions to Authors of ANTICANCER RESEARCH apply to this special issue, in the same way they apply to any ANTICANCER RESEARCH issue.
4. Review articles should preferably not exceed 12 printed pages, corresponding to roughly 48 typewritten pages or roughly 12,000 words. There will be no page charges. Color figures should be charged US $350 per page.
5. Original articles up to 4 printed pages corresponding to roughly 12 typewritten pages or roughly 4,000 words will not be subject to page charges. Articles exceeding 4 printed pages will be charged US $230 per excess page. Color figures will be charged US $350 per page. Discounts will be provided for long articles or/and articles with >2 color pages.
6. All submitted articles will be peer-reviewed. Upon acceptance each article will be edited for language and style improvements (if needed and at no cost) by our philological department. Authors will receive a response within 3-4 weeks from submission.
7. The special issue is scheduled for publication in October 2025.
8. Manuscripts should be submitted for publication through our new online submission system: www.iiar-submissions.com
The Special Issue of Anticancer Research on NEW ANTICANCER AGENTS 2024 is now published
and can be found here.
Articles in ANTICANCER RESEARCH are fully available to everyone as open access 2 years after publication.
Library Recommendation Form
Please print and complete this form. Send or give the completed form to your librarian to recommend Anticancer Research.
Thank you.
Contents of Current Issue
Archive of All Online Issues (January 2004 – Present)
 |
Your link to essential information on cancer research published in the last 43 years.
|
ANTICANCER RESEARCH USA, Inc.
111 Bay Avenue, Highlands, NJ 07732, USA.
e-mail: journals@iiar-anticancer.org
Information – Editorial & Production Office:
Managing Editor: G. J. Delinasios, International Institute of Anticancer Research,
1st km Kapandritiou- Kalamou Rd., P.O.Box 22, Kapandriti, Attiki 19014, Greece.
Tel & Fax : +30-22950-52945, +30-22950-53389
e-mail:journals@iiar-anticancer.org